NAUTILUS, INC.

VANCOUVER, WA · CIK 0001078207 · Biotech · Private

Proteomics platform for comprehensive protein analysis

nautilus.bio →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
—
1 Form D · Aug 2023
38 months since last filing
Contracts
—
No federal contracts on record
Patents
40
38 granted · 2 pending
Sector median: 2

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2920PARION SCIENCES, INC.——
2921VINCERE BIOSCIENCES INC——
2922AADI, LLC——
2923NAUTILUS, INC.——
2924CULNEXIN THERAPEUTICS LLC——
2925NewAmsterdam Pharma——
2926TRPBLUE, INC.——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 11 related persons
  • Becky AlsethExecutive Officer
  • James Barr IVDirector · Executive Officer
  • Alan ChanExecutive Officer
  • John GoelzExecutive Officer
  • Kelley HallDirector
  • Aina KonoldExecutive Officer
  • Shailesh PrakashDirector
  • Christopher QuatrochiExecutive Officer
  • Patricia RossDirector
  • Anne SaundersDirector
  • Ruby SharmaDirector

Patents

USPTO · 38 granted of 40

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.